Changes in Hypertension Prevalence, Awareness, Treatment, and Control in High-, Middle-, and Low-Income Countries: An Update

Current Hypertension Reports

Volumn 18, Issue 8, 2016, Pages

  Cifkova, Renata ^a,b   Fodor, George ^c   Wohlfahrt, Peter ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^c UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Epidemiology; Hypertension; Lifestyle changes; Pharmacotherapy

Indexed keywords

AWARENESS; DISEASE ASSOCIATION; DISEASE CONTROL; GEOGRAPHIC AND GEOLOGICAL PHENOMENA; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HIGH INCOME COUNTRY; HUMAN; HYPERTENSION; LOW INCOME COUNTRY; MIDDLE INCOME COUNTRY; NORTH AMERICA; OUTCOME ASSESSMENT; PATIENT EDUCATION; PREVALENCE; REVIEW; ADOLESCENT; ADULT; AGED; ATTITUDE TO HEALTH; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; CULTURAL FACTOR; FEMALE; HEALTHY LIFESTYLE; MALE; MIDDLE AGED; POVERTY; SOCIOECONOMICS; TREATMENT OUTCOME; YOUNG ADULT;

ANTIHYPERTENSIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTHY LIFESTYLE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POVERTY; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84977136793     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-016-0669-y     Document Type: Review

References (36)

1. http://www.who.int/mediacentre/factsheets/fs317/en/accessed 18.04.2016.
2. Chobanian AV. Shattuck Lecture. The hypertension paradox—more uncontrolled disease despite improved therapy. N Engl J Med. 2009;361(9):878–87. doi:10.1056/NEJMsa0903829.
3. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23.
4. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2014;2(8):634–47. doi:10.1016/S2213-8587(14)70102-0. CVD, CKD, and diabetes mortality attributable to elevated BP and glucose serum cholesterol, and BMI were estimated.
5. Wilber JA, Barrow JG. Hypertension—a community problem. Am J Med. 1972;52(5):653–63.
6. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004;43(1):10–7.
7. Yoon SS, Fryar CD, Carroll MD. Hypertension prevalence and control among adults: United States, 2011–2014. U.S. National Center Health Statistics, Data Brief No. 220, 8 pp. (PHS) 2016-1209. November 2015.
8. Leenen FH, Dumais J, McInnis NH, Turton P, Stratychuk L, Nemeth K, Moy Lum-Kwong M, Fodor G. Results of the Ontario survey on the prevalence and control of hypertension. CMAJ 2008 20;178(11):1441–9. doi: 10.1503/cmaj.071340.
9. McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, Gee M, et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ. 2011;183(9):1007–13. doi:10.1503/cmaj.101767.
10. Myers MG, McInnis NH, Fodor GJ, Leenen FH. Comparison between an automated and manual sphygmomanometer in a population survey. Am J Hypertens. 2008;21(3):280–3. doi:10.1038/ajh.2007.54.
11. Törmä E, Carlberg B, Eriksson M, Jansson JH, Eliasson M. Long term trends in control of hypertension in the Northern Sweden MONICA study 1986-2009. BMC Public Health. 2015;15:957. doi:10.1186/s12889-015-2280-6.
12. Rückert IM, Baumert J, Schunk M, Holle R, Schipf S, Völzke H, et al. Blood pressure control has improved in people with and without type 2 diabetes but remains suboptimal: a longitudinal study based on the German DIAB-CORE consortium. PLoS One. 2015;10(7):e0133493. doi:10.1371/journal.pone.0133493. eCollection 2015.
13. Neuhauser HK, Adler C, Rosario AS, Diederichs C, Ellert U. Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008–11. J Hum Hypertens. 2015;29(4):247–53. doi:10.1038/jhh.2014.82.
14. Polonia J, Martins L, Pinto F, Nazare J. Prevalence, awareness, treatment and control of hypertension and salt intake in Portugal: changes over a decade. PHYSA study J Hypertens. 2014;32(6):1211–21. doi:10.1097/HJH.0000000000000162.
15. Reklaitiene R, Tamosiunas A, Virviciute D, Baceviciene M, Luksiene D. Trends in prevalence, awareness, treatment, and control of hypertension, and the risk of mortality among middle-aged Lithuanian urban population in 1983–2009. BMC Cardiovasc Disord. 2012;12:68. doi:10.1186/1471-2261-12-68.
16. Dorobanţu M, Darabont R, Ghiorghe S, Arsenescu-Georgescu C, Macarie C, Mitu F, et al. Hypertension prevalence and control in Romania at a seven-year interval. Comparison of SEPHAR I and II surveys. J Hypertens. 2014;32(1):39–47. doi:10.1097/01.hjh.0000434937.62412.24.
17. Lovic D, Stojanov V, Jakovljević B, Krotin M, Jurisic V, Djordjevic D, et al. Prevalence of arterial hypertension in Serbia: PAHIS study. J Hypertens. 2013;31(11):2151–7. doi:10.1097/HJH.0b013e328364c2a2. discussion 2157.
18. Liao Y, Gilmour S, Shibuya K. Health insurance coverage and hypertension control in China: results from the China Health and Nutrition Survey. PLoS One. 2016;11(3):e0152091. doi:10.1371/journal.pone.0152091. eCollection 2016.
19. Sengul S, Akpolat T, Erdem Y, Derici U, Arici M, Sindel S, Karatan O, Turgan C, Hasanoglu E, Caglar S, Erturk S; Turkish Society of Hypertension and Renal Diseases. Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012. J Hypertens 2016 Mar 17. [Epub ahead of print]
20. Anchala R, Kannuri NK, Pant H, Khan H, Franco OH, Di Angelantonio E, et al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014;32(6):1170–7. doi:10.1097/HJH.0000000000000146. A systematic review of epidemiology of hypertension in India from 1950 to 2013.
21. Jin C-N, Yu C-M, Sun J-P, Fang F, Wen Y-N, Liu M, et al. The healthcare burden of hypertension in Asia. Heart Asia. 2013;5:238–43.
22. Basu S, Millett C. Social epidemiology of hypertension in middle-income countries: determinants of prevalence, diagnosis, treatment, and control in the WHO SAGE study. Hypertension. 2013;62(1):18–26. doi:10.1161/HYPERTENSIONAHA.113.01374. Identification of socio-demographic predictors of hypertension prevalence, diagnosis, treatment, and control in 6 middle-income countries.
23. Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui JB, Kengne AP. Burden of undiagnosed hypertension in sub-saharan Africa: a systematic review and meta-analysis. Hypertension. 2015;65(2):291–8. doi:10.1161/HYPERTENSIONAHA.114.04394. A systematic review of hypertension studies in sub-Saharan Africa between 2000 and 2013.
24. Bosu WK. The prevalence, awareness, and control of hypertension among workers in West Africa: a systematic review. Glob Health Action. 2015;8:26227. doi:10.3402/gha.v8.26227. eCollection 2015.
25. Neupane D, McLachlan CS, Sharma R, Gyawali B, Khanal V, Mishra SR, et al. Prevalence of hypertension in member countries of South Asian Association for Regional Cooperation (SAARC): systematic review and meta-analysis. Medicine (Baltimore). 2014;93(13):e74. doi:10.1097/MD.0000000000000074.
26. Redón J, Cea-Calvo L, Lozano JV, Martí-Canales JC, Llisterri JL, Aznar J. González-Esteban J; on behalf of the investigators of the PREV-ICTUS Study. Differences in blood pressure control and stroke mortality across Spain. The Prevención de Riesgo de Ictus (PREV-ICTUS) Study. Hypertension. 2007;49(4):799–805.
27. Cooper RS. Using public health indicators to measure the success of hypertension control. Hypertension 2007;49(4):773–4. Epub 2007 Feb 19. No abstract available.
28. Redon J, Olsen MH, Cooper RS, Zurriaga O, Martinez-Beneito MA, Laurent S, et al. Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure. Eur Heart J. 2011;32(11):1424–31. doi:10.1093/eurheartj/ehr045.
29. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson L, Truelsen T, O'Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C; Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2014;383(9913):245–54. Review. Erratum in: Lancet 2014;383(9913):218. This study is the first to report the global burden of stroke (incidence, prevalence, mortality, DALYs lost, and mortality-to-incidence ratios).
30. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension. 2008;52(5):818–27. doi:10.1161/HYPERTENSIONAHA.108.113357.
31. http://www.who.int/nmh/events/un_ncd_summit2011/political_declaration_en.pdf; accessed 22.04.2016.
32. O'Donnell M, Mente A, Yusuf S. Commentary: accepting what we don't know will lead to progress. Int J Epidemiol. 2016;45(1):260–2. doi:10.1093/ije/dyw014.
33. Webster JL, Dunford EK, Hawkes C, Neal BC. Salt reduction initiatives around the world. J Hypertens. 2011;29(6):1043–50. doi:10.1097/HJH.0b013e328345ed83.
34. Semlitsch T, Jeitler K, Berghold A, Horvath K, Posch N, Poggenburg S, Siebenhofer A. Long-term effects of weight-reducing diets in people with hypertension. Cochrane Database of Systematic Reviews 2016, Issue 3. Art. No.: CD008274. DOI:10.1002/14651858.CD008274.pub3.
35. Cutler DM, Long G, Berndt ER, Royer J, Fournier AA, Sasser A, et al. The value of antihypertensive drugs: a perspective on medical innovation. Health Aff (Millwood). 2007;26(1):97–110.
36. Oparil S, Schmieder RE. New approaches in the treatment of hypertension. Circ Res. 2015;116(6):1074–95. doi:10.1161/CIRCRESAHA.116.303603.